Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Non-Current Deffered Revenue (2025 - 2026)

Camp4 Therapeutics' Non-Current Deffered Revenue history spans 1 years, with the latest figure at $8.1 million for Q4 2025.

  • On a quarterly basis, Non-Current Deffered Revenue changed N/A to $8.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.1 million, a N/A change, with the full-year FY2025 number at $8.1 million, changed N/A from a year prior.
  • Non-Current Deffered Revenue hit $8.1 million in Q4 2025 for Camp4 Therapeutics.
  • Over the last five years, Non-Current Deffered Revenue for CAMP hit a ceiling of $8.1 million in Q4 2025 and a floor of $8.1 million in Q4 2025.